Our expertise in nuclear medicine, radiology and trial management, has enabled us to become a leader in the medical imaging industry.

As of today, we have reached a level of maturity and technological knowledge allowing us to foresee the future of the company with renewed ambitions.

In order to increase and accelerate our international expansion, we strive to innovate and continuously bring new solutions to the market. Our success is driven by the expansion of our network of experts specialized in modalities, treatments and diseases, more particularly in the following fields: oncology, cardiology, musculoskeletal and CNS.

By focusing on the latest industry developments, we are able to adapt our know-how and ultimately meet our market’s evolving needs.

The opening of our Singapore office in 2013 demonstrates our will to approach the Asian market’s rising demand. This year, we are proud to announce the incorporation of our North American subsidiary in Philadelphia, PA.